Targeted therapy in Austria typically costs from $12,000 to $28,000. The final price depends on the molecular profile of the tumor and drug costs. In the US, similar procedures cost around $40,000 on average. Patients save around 50% compared to the US. Costs in Austria usually include initial consultations and tumor board reviews.
Bookimed Expert Insight: While Vienna carries a premium, the value lies in accessing world-class university expertise. At Wiener Privatklinik, over 400 physicians collaborate, many serving as professors at Medical University of Vienna. Expert oncologists like Dr. Wolfgang Köstler bring experience from Memorial Sloan-Kettering Cancer Center. This academic connection ensures patients receive the latest personalized medicine protocols. Initial oncology consultations in Vienna typically run approximately $400 to $500.
Why choose Austria for targeted therapy?
Access advanced Targeted therapy solutions in trusted clinics .
| Turkey | Austria | Spain | |
| Targeted therapy | from $1,000 | from $12,000 | from $15,000 |
| Lutetium-177 therapy | from $8,800 | from $35,000 | from $12,000 |
| Actinium-225 Therapy | from $22,955 | from $55,000 | from $45,000 |
| Oncothermia | from $450 | - | - |
No hidden fees – just official clinic prices. Pay at the clinic for Targeted therapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Targeted therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Targeted therapy journey.
Day 1: Arrival
Day 2: Pre-Operation Stage
Day 3: Targeted Therapy
Day 4: Post-Operation Stage
Week 1-2: Rehabilitation
Please note that each patient"s case is individual and can vary.
As the leading global medical tourism platform, we have a huge responsibility before our clients — both patients and medical centers in Austria. All the information provided on Bookimed.com is grounded in research, foresight, and expertise and meets high interest related to the product and follows:
We form our listings of clinics and doctors with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services in Austria there.
Our experienced data scientist collects data daily, monitors, and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
We collect the opinions of Bookimed clients only after getting medical experience with the clinic in Austria — so everyone on the platform can trust the facility they choose. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com you may find choice and convenience to find the best medical solutions from top medical services providers in Austria just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Our blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value in Austria. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com, please feel free to contact us at marketing@bookimed.com.
22 years of experience specializing in targeted therapies – Prof. Köstler leads pioneering work in personalized cancer medicine at Wiener Privatklinik.
Dr. Christoph Zielinski is a prominent oncologist and Chairman of the Vienna Cancer Center. He serves as Medical Director of the International Oncology Center at Wiener Privatklinik. Dr. Zielinski specializes in immunotherapy and hematology. He has published over 600 scientific papers on individualized cancer treatment. Dr. Zielinski works at Wiener Privatklinik, a hospital ranked among the world's best by Newsweek.
Written by Anna Shchur
When considering Targeted therapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
Lutetium-177 therapy is a targeted radiotherapy utilizing the Lutetium-177 radioisotope to treat certain cancers effectively.
Targeted therapy in Austria is a precision medicine approach using molecular oncology to block specific proteins or genes fueling cancer growth. Austrian clinics like Wiener Privatklinik utilize next-generation sequencing and biomarker testing to create individualized systemic treatments that spare healthy tissue and minimize systemic side effects.
Bookimed Expert Insight: While basic oncology is widespread, Austria stands out for its high density of molecular biology experts. At Wiener Privatklinik, surgeons like Professor Wolfgang Köstler combine clinical work with research from the Weizmann Institute. This allows patients to access specific targeted drugs that effectively overcome tumor resistance patterns.
Patient Consensus: Patients emphasize that accessing these therapies requires providing detailed documentation of all previous treatments. Consensus suggests focusing on major oncology centers since targeted options are rarely available as walk-in services.
Top medical centers in Austria for precision oncology include Wiener Privatklinik (WPK), Vienna General Hospital (AKH), and University Hospital Innsbruck. These facilities utilize molecular profiling and targeted systemic therapies to treat cancer based on genetic biomarkers. Patients access advanced drug protocols and high-tech radiation like carbon-ion therapy.
Bookimed Expert Insight: While Vienna is the primary academic hub, private clinics like WPK offer unique accessibility. With 300 doctors and 12,000 annual patients, WPK provides rapid molecular results. This speed is critical for initiating targeted therapies compared to larger public systems.
Patient Consensus: Patients emphasize that Austria is a top destination for subspecialized cancer care. They recommend prioritizing large tertiary centers for complex cases to ensure access to molecular tumor boards.
Austrian oncology centers provide targeted therapy for breast, lung, colorectal, and prostate cancers. Treatment protocols utilize molecular profiling and biomarker testing to identify specific genetic mutations. Specialized clinics like Wiener Privatklinik integrate personalized medicine, leveraging monoclonal antibodies, tyrosine kinase inhibitors, and advanced radioligand therapies.
Bookimed Expert Insight: While many countries offer standard targeted drugs, Austria stands out for its molecular oncology leadership. Clinics like Wiener Privatklinik host top experts like Dr. Wolfgang Köstler. His background at Memorial Sloan–Kettering highlights the focus on overcoming drug resistance. This expertise is vital when first-line therapies fail.
Patient Consensus: Patients emphasize that targeted therapy is mutation-driven rather than a general solution. Many suggest seeking care at specialized oncology centers to ensure access to comprehensive molecular profiling.
International patients arrange consultations for targeted therapy in Austria by contacting specialized international offices at private Vienna hospitals. The process involves submitting molecular profiling results and pathology reports for multidisciplinary tumor board review. Leading oncologists provide remote second opinions and individualized systemic therapy plans via telehealth portals.
Bookimed Expert Insight: Vienna clinics like Wiener Privatklinik handle over 7,000 international patients annually, reflecting a high-volume infrastructure for cross-border care. Dr. Wolfgang Köstler combines molecular biology expertise with clinical oncology, which is vital for patients seeking specific resistance mechanism analysis. Choosing a clinic with ISO 9001 certification ensures standardized documentation for seamless second opinions.
Patient Consensus: Patients recommend sending a concise summary from a home oncologist to accelerate the triage process. Clarity on whether the visit is for a second opinion or immediate treatment helps manage financial expectations early.